|
Messe Frankfurt India and Andhra
Pradesh MedTech Zone (AMTZ) join hands to launch MedTech Innovation Forum in
India
With an objective to draw attention to the
growth opportunities and latest developments in the Indian Medical device
industry, Messe Frankfurt Trade Fairs India has joined
hands with India’s first integrated medical devices manufacturing ecosystem –
AMTZ. The joint cooperation aims to provide further impetus to indigenous
manufacturing of medical devices and bring forward innovations and specialised
medical tools and technologies that can attract domestic and global investors.
As the nation takes steps to develop its healthcare
infrastructure including an ecosystem for its medical device industry, the
launch of MedTech Innovation Forum aims to create a collaborative platform for
medical device manufacturers, innovators and technology experts to exchange
advancements and innovations for the development of the Indian medical devices
industry.
Slated from 7 – 8 October 2021 in Visakhapatnam,
the first edition of this key business event is expected to bring industry
leadership together with government and medical consultants to address integral
challenges of import dependency, need for technology collaborations as well as
medical technology advancements that can be introduced in the industry. The
forum has received strong support from apex industry bodies – AIMED (Association
of Indian Medical Device Industry) and ADMI (Association of Diagnostics
Manufacturers of India) ADMI.
Commenting on the development, Mr Raj Manek,
Managing Director, Messe Frankfurt Trade Fairs India Pvt Ltd said: “India’s
response and agility in scaling up manufacturing of medical devices together
with strong initiatives by the government on making the sector ‘Atmanirbhar’
makes it opportune time to introduce a forum that focuses on bringing medical
technology innovations to the forefront. We are proud to combine strengths with
AMTZ in this goal and are confident that the critical insights on MedTech
advancements and challenges will enable the sector to create an environment for
improved trade and investment opportunities.”
The Indian medical devices market, which accounts
for more than 13% of the Asia-Pacific (APAC) medical devices market, is expected
to grow at a compound annual growth rate of 7.5% through 2025. Dr Jitendra
Sharma, MD & CEO, Andhra Pradesh MedTech Zone elaborated: “The industry is
poised for significant growth in the next five years, however, it is still
largely importdriven with 90% of sophisticated devices being imported from
around the world. The dialogue with medical device manufacturers and innovators
will open up opportunities to empower the country’s strong healthcare and
medical devices industry in the post COVID-19 era.
Dr Sharma further added that AMTZ aims to put the
Indian medical device industry on the global map by encouraging sector
innovations and we are happy to join hands with Messe Frankfurt in this
endeavour as their expertise and reach across sectors in India will help bring
in key stakeholders together.”
Messe Frankfurt India has been actively involved in
tracking industry growth and addressing rising concerns on counterfeit products
in the pharmaceutical industry through its Pharmasafe India conference and
webinar series. In August 2020, the Indian subsidiary held the first virtual
edition of the Medical Device Innovation Summit to address growing demand for
specialised medical equipment and is now closely working with industry leaders
in the sector to launch Medtech Innovation Forum as a large-format Confex in
October 2021.
Touted as India’s largest medical devices
manufacturing park, the Andhra Pradesh Medtech Zone (AMTZ) has dynamically
contributed to the fight against COVID-19 pandemic through large-scale
manufacturing of domestic rapid testing kits, PPE and ventilators. As a
scientific infrastructure supported by the government, the zone intends to
reduce import dependence and lower cost of healthcare by an estimated 40 to 50
per cent and is taking active steps to develop R&D, testing labs and provision
for acceleration for start-ups.
https://www.eventindustrynews.com
Intake Of Students In Medical
Devices Courses At NIPERs Increased To Strengthen Manpower Resources
Intake of students in medical devices courses at
National Institute of Pharmaceutical Education and Research (NIPER) Mohali,
Guwahati and Hyderabad has been increased to strengthen manpower resources for
medical devices sector in the country.
Admission of 34 students has been made for the new
course of M Tech (Medical Devices) with 11 seats in NIPER Mohali, nine in NIPER
Guwahati and twelve in NIPER Hyderabad.
The government is also planning to explore every
prospect of revenue generation in the existing seven NIPERs in the country to
help them evolve into self-sustaining premier institutions. At present, there
are seven NIPERs across the country at Mohali, Ahmedabad, Hyderabad, Rae Bareli,
Guwahati, Hajipur and Kolkata.
The Government of India has termed NIPERs as
Institutes of National Importance.
The Centre also has plans to strengthen
industry-academia linkages which can also be leveraged to commercialize patents
which are held by NIPERs.
The Union minister for chemicals and fertilizers D
V Sadananda Gowda and Minister of State (MoS) for chemicals and fertilizers
Mansukh Mandaviya had held a review meeting last year in the month of September
to monitor functioning of NIPER Mohali and Rae Bareli through video
conferencing. The meeting was also attended by Department of Pharmaceuticals (DoP)
secretary Dr P D Vaghela and other senior officers.
NIPERs across the country play an important role in
the development of upcoming bulk drug and medical device parks and the Centre
has renewed its focus on drug discovery for diseases like TB, malaria, kala azar,
cancer, diabetes, obesity, drug repurposing and drug development.
NIPERs across the country are today being developed
as centers of excellence as R&D is the thrust of the present government with
priority to support the MSME sector through extension of services like testing,
consultancy and incubation centers.
NIPER Mohali has been ranked 3rd and NIPER
Raebareli at 18th by NIRF in the pharmacy sector.
NIPERs are national level institutes in
pharmaceutical sciences with the objective of becoming centres of excellence for
advanced studies and research in pharmaceutical sciences.
http://www.pharmabiz.com/NewsDetails.aspx?aid=135041&sid=1
|
